MS-DRG v44.0 · MDC 15: Newborns and Other Neonates with Conditions Originating in the Perinatal Period
794 — Neonate with Other Significant Problems
- Relative weight
- 1.4935
- Geometric mean LOS
- 3.4 days
- Arithmetic mean LOS
- 3.4 days
- Type
- Medical
About MS-DRG 794
MS-DRG 794, Neonate with Other Significant Problems, is a medical DRG in MDC 15 (Newborns and Other Neonates with Conditions Originating in the Perinatal Period) under MS-DRG version 44.0, which applies to inpatient discharges from October 1, 2026 through September 30, 2027.
Its FY2027 relative weight is 1.4935, so Medicare's base payment for this DRG is about 1.49 times the average inpatient case, before hospital-specific adjustments. The geometric mean length of stay is 3.4 days and the arithmetic mean is 3.4 days.
201 ICD-10-CM diagnosis codes are part of this DRG's grouping logic; they are listed below.
ICD-10-CM codes that group to DRG 794 (201)
Chapter 1: Certain infectious and parasitic diseases
Chapter 16: Certain conditions originating in the perinatal period
- P00.0Newborn affected by maternal hypertensive disorders
- P00.1Newborn affected by maternal renal and urinary tract diseases
- P00.4Newborn affected by maternal nutritional disorders
- P00.5Newborn affected by maternal injury
- P00.6Newborn affected by surgical procedure on mother
- P00.7Newborn affected by other medical procedures on mother, not elsewhere classified
- P00.81Newborn affected by periodontal disease in mother
- P01.0Newborn affected by incompetent cervix
- P01.1Newborn affected by premature rupture of membranes
- P01.2Newborn affected by oligohydramnios
- P01.3Newborn affected by polyhydramnios
- P01.4Newborn affected by ectopic pregnancy
- P01.5Newborn affected by multiple pregnancy
- P01.6Newborn affected by maternal death
- P01.7Newborn affected by malpresentation before labor
- P01.8Newborn affected by other maternal complications of pregnancy
- P01.9Newborn affected by maternal complication of pregnancy, unspecified
- P02.0Newborn affected by placenta previa
- P02.1Newborn affected by other forms of placental separation and hemorrhage
- P02.20Newborn affected by unspecified morphological and functional abnormalities of placenta
- P02.29Newborn affected by other morphological and functional abnormalities of placenta
- P02.3Newborn affected by placental transfusion syndromes
- P02.70Newborn affected by fetal inflammatory response syndrome
- P02.78Newborn affected by other conditions from chorioamnionitis
- P02.8Newborn affected by other abnormalities of membranes
- P02.9Newborn affected by abnormality of membranes, unspecified
- P03.6Newborn affected by abnormal uterine contractions
- P03.810Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm before the onset of labor
- P03.811Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm during labor
- P03.819Newborn affected by abnormality in fetal (intrauterine) heart rate or rhythm, unspecified as to time of onset
- P03.82Meconium passage during delivery
- P03.89Newborn affected by other specified complications of labor and delivery
- P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
- P04.11Newborn affected by maternal antineoplastic chemotherapy
- P04.12Newborn affected by maternal cytotoxic drugs
- P04.13Newborn affected by maternal use of anticonvulsants
- P04.14Newborn affected by maternal use of opiates
- P04.15Newborn affected by maternal use of antidepressants
- P04.16Newborn affected by maternal use of amphetamines
- P04.17Newborn affected by maternal use of sedative-hypnotics
- P04.18Newborn affected by other maternal medication
- P04.19Newborn affected by maternal use of unspecified medication
- P04.1ANewborn affected by maternal use of anxiolytics
- P04.2Newborn affected by maternal use of tobacco
- P04.3Newborn affected by maternal use of alcohol
- P04.40Newborn affected by maternal use of unspecified drugs of addiction
- P04.41Newborn affected by maternal use of cocaine
- P04.42Newborn affected by maternal use of hallucinogens
- P04.49Newborn affected by maternal use of other drugs of addiction
- P04.5Newborn affected by maternal use of nutritional chemical substances
- P04.6Newborn affected by maternal exposure to environmental chemical substances
- P04.81Newborn affected by maternal use of cannabis
- P04.89Newborn affected by other maternal noxious substances
- P04.9Newborn affected by maternal noxious substance, unspecified
- P05.00Newborn light for gestational age, unspecified weight
- P05.01Newborn light for gestational age, less than 500 grams
- P05.02Newborn light for gestational age, 500-749 grams
- P05.03Newborn light for gestational age, 750-999 grams
- P05.04Newborn light for gestational age, 1000-1249 grams
- P05.05Newborn light for gestational age, 1250-1499 grams
- P05.06Newborn light for gestational age, 1500-1749 grams
- P05.07Newborn light for gestational age, 1750-1999 grams
- P05.09Newborn light for gestational age, 2500 grams and over
- P05.10Newborn small for gestational age, unspecified weight
- P05.9Newborn affected by slow intrauterine growth, unspecified
- P11.1Other specified brain damage due to birth injury
- P11.3Birth injury to facial nerve
- P13.0Fracture of skull due to birth injury
- P13.1Other birth injuries to skull
- P13.2Birth injury to femur
- P13.3Birth injury to other long bones
- P13.4Fracture of clavicle due to birth injury
- P13.8Birth injuries to other parts of skeleton
- P13.9Birth injury to skeleton, unspecified
- P14.0Erb's paralysis due to birth injury
- P14.1Klumpke's paralysis due to birth injury
- P14.3Other brachial plexus birth injuries
- P15.0Birth injury to liver
- P15.1Birth injury to spleen
- P15.2Sternomastoid injury due to birth injury
- P15.3Birth injury to eye
- P15.4Birth injury to face
- P15.5Birth injury to external genitalia
- P15.6Subcutaneous fat necrosis due to birth injury
- P15.8Other specified birth injuries
- P15.9Birth injury, unspecified
- P19.0Metabolic acidemia in newborn first noted before onset of labor
- P19.1Metabolic acidemia in newborn first noted during labor
- P19.2Metabolic acidemia noted at birth
- P19.9Metabolic acidemia in newborn, unspecified
- P22.1Transient tachypnea of newborn
- P22.8Other respiratory distress of newborn
- P22.9Respiratory distress of newborn, unspecified
- P28.10Unspecified atelectasis of newborn
- P28.11Resorption atelectasis without respiratory distress syndrome
- P28.19Other atelectasis of newborn
- P28.2Cyanotic attacks of newborn
- P28.30Primary sleep apnea of newborn, unspecified
- P28.31Primary central sleep apnea of newborn
- P28.32Primary obstructive sleep apnea of newborn
- P28.33Primary mixed sleep apnea of newborn
- P28.39Other primary sleep apnea of newborn
- P28.40Unspecified apnea of newborn
- P28.41Central neonatal apnea of newborn
- P28.42Obstructive apnea of newborn
- P28.43Mixed neonatal apnea of newborn
- P28.49Other apnea of newborn
- P28.81Respiratory arrest of newborn
- P28.89Other specified respiratory conditions of newborn
- P28.9Respiratory condition of newborn, unspecified
- P29.0Neonatal cardiac failure
- P29.11Neonatal tachycardia
- P29.12Neonatal bradycardia
- P29.2Neonatal hypertension
- P29.4Transient myocardial ischemia in newborn
- P29.89Other cardiovascular disorders originating in the perinatal period
- P29.9Cardiovascular disorder originating in the perinatal period, unspecified
- P37.5Neonatal candidiasis
- P39.1Neonatal conjunctivitis and dacryocystitis
- P51.0Massive umbilical hemorrhage of newborn
- P51.8Other umbilical hemorrhages of newborn
- P51.9Umbilical hemorrhage of newborn, unspecified
- P54.0Neonatal hematemesis
- P54.6Neonatal vaginal hemorrhage
- P54.8Other specified neonatal hemorrhages
- P54.9Neonatal hemorrhage, unspecified
- P55.0Rh isoimmunization of newborn
- P55.1ABO isoimmunization of newborn
- P58.0Neonatal jaundice due to bruising
- P58.1Neonatal jaundice due to bleeding
- P58.2Neonatal jaundice due to infection
- P58.3Neonatal jaundice due to polycythemia
- P58.41Neonatal jaundice due to drugs or toxins transmitted from mother
- P58.42Neonatal jaundice due to drugs or toxins given to newborn
- P58.5Neonatal jaundice due to swallowed maternal blood
- P58.8Neonatal jaundice due to other specified excessive hemolysis
- P58.9Neonatal jaundice due to excessive hemolysis, unspecified
- P59.0Neonatal jaundice associated with preterm delivery
- P61.1Polycythemia neonatorum
- P61.3Congenital anemia from fetal blood loss
- P61.4Other congenital anemias, not elsewhere classified
- P61.5Transient neonatal neutropenia
- P61.8Other specified perinatal hematological disorders
- P61.9Perinatal hematological disorder, unspecified
- P70.0Syndrome of infant of mother with gestational diabetes
- P70.1Syndrome of infant of a diabetic mother
- P70.8Other transitory disorders of carbohydrate metabolism of newborn
- P70.9Transitory disorder of carbohydrate metabolism of newborn, unspecified
- P72.0Neonatal goiter, not elsewhere classified
- P72.2Other transitory neonatal disorders of thyroid function, not elsewhere classified
- P72.8Other specified transitory neonatal endocrine disorders
- P72.9Transitory neonatal endocrine disorder, unspecified
- P74.41Alkalosis of newborn
- P74.5Transitory tyrosinemia of newborn
- P74.6Transitory hyperammonemia of newborn
- P74.8Other transitory metabolic disturbances of newborn
- P74.9Transitory metabolic disturbance of newborn, unspecified
- P76.1Transitory ileus of newborn
- P76.8Other specified intestinal obstruction of newborn
- P76.9Intestinal obstruction of newborn, unspecified
- P78.1Other neonatal peritonitis
- P78.2Neonatal hematemesis and melena due to swallowed maternal blood
- P78.3Noninfective neonatal diarrhea
- P78.81Congenital cirrhosis (of liver)
- P78.82Peptic ulcer of newborn
- P78.83Newborn esophageal reflux
- P78.84Gestational alloimmune liver disease
- P78.89Other specified perinatal digestive system disorders
- P78.9Perinatal digestive system disorder, unspecified
- P80.0Cold injury syndrome
- P80.8Other hypothermia of newborn
- P80.9Hypothermia of newborn, unspecified
- P81.0Environmental hyperthermia of newborn
- P81.8Other specified disturbances of temperature regulation of newborn
- P81.9Disturbance of temperature regulation of newborn, unspecified
- P83.0Sclerema neonatorum
- P83.30Unspecified edema specific to newborn
- P83.39Other edema specific to newborn
- P83.4Breast engorgement of newborn
- P83.5Congenital hydrocele
- P83.9Condition of the integument specific to newborn, unspecified
- P84Other problems with newborn
- P91.60Hypoxic ischemic encephalopathy [HIE], unspecified
- P91.61Mild hypoxic ischemic encephalopathy [HIE]
- P94.1Congenital hypertonia
- P94.2Congenital hypotonia
- P94.8Other disorders of muscle tone of newborn
- P94.9Disorder of muscle tone of newborn, unspecified
- P95Stillbirth
- P96.0Congenital renal failure
- P96.3Wide cranial sutures of newborn
- P96.5Complication to newborn due to (fetal) intrauterine procedure
- P96.81Exposure to (parental) (environmental) tobacco smoke in the perinatal period
- P96.83Meconium staining
- P96.89Other specified conditions originating in the perinatal period
- P96.9Condition originating in the perinatal period, unspecified
Chapter 17: Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders
Common questions about DRG 794
What is the relative weight of DRG 794?
- 1.4935 for FY2027 (MS-DRG v44.0), from the IPPS final rule Table 5.
What is the average length of stay for DRG 794?
- The geometric mean length of stay is 3.4 days; the arithmetic mean is 3.4 days.
Is DRG 794 medical or surgical?
- DRG 794 is a medical DRG.